Literature DB >> 15217590

Nonclinical factors associated with primary care physicians' ordering patterns of magnetic resonance imaging/computed tomography for headache.

Glen R Couchman1, Samuel N Forjuoh, Mohammad H Rajab, Charles D Phillips, Jihnhee Yu.   

Abstract

RATIONALE AND
OBJECTIVES: The purpose of ordering an imaging test for headache, which is one of the most common reasons for patient consultation with a primary care physician (PCP), include medical indications as well as patient anxiety and medico-legal concerns. The impact of nonclinical factors on PCPs' ordering patterns of magnetic resonance imaging/computed tomography for patients presenting with a headache was examined.
MATERIALS AND METHODS: A retrospective record review of all patients treated for headache as their primary complaint by a PCP from a multispecialty group practice associated with an 180,000-member Health Maintenance Organization during calendar year 2000 was examined. The practice included 18 clinics. Logistic regression was used to estimate the association between physician ordering patterns of imaging tests and patient, physician, and clinic setting characteristics.
RESULTS: Of the total study subjects (n = 4,372), a magnetic resonance imaging/computed tomography imaging test was ordered for 5.3%. At their first encounter, patient's gender, site of care, and insurance status under the health care system's Health Maintenance Organization had statistically significant associations with the likelihood of imaging test orders. Female physicians were less likely to order an imaging test (OR = 0.65; 95% confidence interval, 0.39-1.08). For subsequent encounters, however, site of care was the only nonclinical factor that had a consistent association with the likelihood of having a magnetic resonance imaging/computed tomography ordered.
CONCLUSION: These data show that a number of nonclinical factors may have been associated with having an imaging test ordered by a PCP when patients presented with a headache. These factors were more significant when the patient was being seen for the first time with this complaint.

Entities:  

Mesh:

Year:  2004        PMID: 15217590     DOI: 10.1016/j.acra.2004.03.050

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  6 in total

1.  Should GPs have direct access to neuroradiological investigation when adults present with headache?

Authors:  David Kernick; Stuart Williams
Journal:  Br J Gen Pract       Date:  2011-06       Impact factor: 5.386

2.  Patient-reported Chiari malformation type I symptoms and diagnostic experiences: a report from the national Conquer Chiari Patient Registry database.

Authors:  Rebecca Fischbein; Julia R Saling; Paige Marty; Denise Kropp; James Meeker; Jenna Amerine; Michelle Renee Chyatte
Journal:  Neurol Sci       Date:  2015-05-14       Impact factor: 3.307

3.  Variation in advanced imaging for pediatric patients with abdominal pain discharged from the ED.

Authors:  Kimberly B Horner; Amy Jones; Li Wang; Daniel G Winger; Jennifer R Marin
Journal:  Am J Emerg Med       Date:  2016-08-26       Impact factor: 2.469

4.  Imaging patients with suspected brain tumour: guidance for primary care.

Authors:  David P Kernick; Fayyaz Ahmed; Anish Bahra; Andrew Dowson; Giles Elrington; Manuela Fontebasso; Nicola J Giffin; Sue Lipscombe; Anne MacGregor; Richard Peatfield; Stuart Weatherby; Tom Whitmarsh; Peter J Goadsby
Journal:  Br J Gen Pract       Date:  2008-12       Impact factor: 5.386

5.  Why do GPs with a special interest in headache investigate headache presentations with neuroradiology and what do they find?

Authors:  Steven Elliot; David Kernick
Journal:  J Headache Pain       Date:  2011-09-29       Impact factor: 7.277

6.  Knowledge, Attitudes, and Management of General Practitioners of the Hospital Districts of Ouagadougou about Migraine (Burkina Faso).

Authors:  A A Dabilgou; A Dravé; J M A Kyelem; A Zoma; C Napon; A Millogo; K Karfo; J Kaboré
Journal:  Pain Res Manag       Date:  2021-11-18       Impact factor: 3.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.